Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1992 1
1993 1
1995 2
1998 1
2011 1
2015 1
2016 1
2017 1
2018 3
2019 1
2020 3
2021 4
2022 1
2023 2
2024 5
2025 5
2026 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

32 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean yan fe[au] (1 results)?
Two-Year Efficacy and Safety of Lebrikizumab in Patients with Moderate-to-Severe Atopic Dermatitis: A Long-Term Extension (ADjoin).
Guttman-Yassky E, Weidinger S, Simpson EL, Gooderham M, Irvine AD, Spelman L, Silverberg JI, ElMaraghy H, DeLuca-Carter L, Piruzeli MLB, Hu C, Yang FE, Pierce E, Bardolet L, Thaçi D. Guttman-Yassky E, et al. Among authors: yang fe. Dermatol Ther (Heidelb). 2025 Aug;15(8):2217-2232. doi: 10.1007/s13555-025-01452-9. Epub 2025 Jun 23. Dermatol Ther (Heidelb). 2025. PMID: 40549127 Free PMC article.
Lebrikizumab improves head/neck/face dermatitis and erythema and does not increase treatment-emergent adverse events of head/neck/face erythema in patients with moderate-to-severe atopic dermatitis.
Murase JE, Eyerich K, Chovatiya R, Hong HC, Bangert C, Strowd L, Deleuran M, Atwater AR, Rueda MJ, Elmaraghy H, Piruzeli MLB, Pau-Charles I, Yang FE, Zhong J, Staumont-Sallé D. Murase JE, et al. Among authors: yang fe. J Dermatolog Treat. 2025 Dec;36(1):2492188. doi: 10.1080/09546634.2025.2492188. Epub 2025 Jul 24. J Dermatolog Treat. 2025. PMID: 40708237 Free article.
Improvement Across Dimensions of Disease with Lebrikizumab Use in Atopic Dermatitis: Two Phase 3, Randomized, Double-Blind, Placebo-Controlled Monotherapy Trials (ADvocate1 and ADvocate2).
Simpson E, Fernández-Peñas P, de Bruin-Weller M, Lio PA, Chu CY, Ezzedine K, Agell H, Casillas M, Ding Y, Yang FE, Pierce E, Bieber T. Simpson E, et al. Among authors: yang fe. Adv Ther. 2025 Jan;42(1):132-143. doi: 10.1007/s12325-024-02974-y. Epub 2024 Sep 9. Adv Ther. 2025. PMID: 39249591 Free PMC article. Clinical Trial.
Improved quality of life in patients treated with lebrikizumab monotherapy is mediated by improvements in itch and sleep: results from two phase III trials in patients with moderate-to-severe atopic dermatitis.
Yosipovitch G, de Bruin-Weller M, Wiseman M, Elberling J, Gutermuth J, Pierce E, Montmayeur S, Yang FE, Ding Y, Bardolet L, Chisolm S. Yosipovitch G, et al. Among authors: yang fe. Clin Exp Dermatol. 2025 May 23;50(6):1188-1192. doi: 10.1093/ced/llae541. Clin Exp Dermatol. 2025. PMID: 39680511 Free article. Clinical Trial.
Chinese guidelines for treatment of adult primary immune thrombocytopenia.
Liu XG, Bai XC, Chen FP, Cheng YF, Dai KS, Fang MY, Feng JM, Gong YP, Guo T, Guo XH, Han Y, Hong LJ, Hu Y, Hua BL, Huang RB, Li Y, Peng J, Shu MM, Sun J, Sun PY, Sun YQ, Wang CS, Wang SJ, Wang XM, Wu CM, Wu WM, Yan ZY, Yang FE, Yang LH, Yang RC, Yang TH, Ye X, Zhang GS, Zhang L, Zheng CC, Zhou H, Zhou M, Zhou RF, Zhou ZP, Zhu HL, Zhu TN, Hou M. Liu XG, et al. Among authors: yang fe. Int J Hematol. 2018 Jun;107(6):615-623. doi: 10.1007/s12185-018-2445-z. Epub 2018 Apr 4. Int J Hematol. 2018. PMID: 29619624 Review.
Lebrikizumab provides stable skin response with no or minimal fluctuations for up to 2 years in patients with atopic dermatitis.
Silverberg JI, Wollenberg A, Stein Gold L, Yosipovitch G, Lio P, Vestergaard C, Ständer S, Carrascosa JM, Gallo G, Casillas M, Ding Y, Yang FE, Pierce E, Agell H, Del Rosso J. Silverberg JI, et al. Among authors: yang fe. Clin Exp Dermatol. 2026 May 26;51(6):1012-1019. doi: 10.1093/ced/llaf490. Clin Exp Dermatol. 2026. PMID: 41206702 Free article. Clinical Trial.
32 results